Hai-Xing Jiang

605 total citations
22 papers, 344 citations indexed

About

Hai-Xing Jiang is a scholar working on Oncology, Hepatology and Epidemiology. According to data from OpenAlex, Hai-Xing Jiang has authored 22 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Hai-Xing Jiang's work include Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Hai-Xing Jiang is often cited by papers focused on Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Hai-Xing Jiang collaborates with scholars based in China. Hai-Xing Jiang's co-authors include Shanyu Qin, Qiulan Huang, Ziyu Liang, Jiaxu Wang, Bang-li Hu, Xiaoyun Guo, Jingmin Deng, Guangnan Liu, Shi Cheng and Fei Wang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Hai-Xing Jiang

22 papers receiving 335 citations

Peers

Hai-Xing Jiang

IMMUN

EPIDE

HEPAT

PHYSI

Palma Aurelia Iacovazzi Italy

Milica Stefanović Spain

Xinxia Feng China

Andrew Soh China

Tomoaki Iwata Japan

Miriam Sklair‐Levy Israel

Chan Xie China

Yoshimi Sugama Japan

Xiaoxin Mu China

Can Gan China

Palma Aurelia Iacovazzi Italy

Hai-Xing Jiang

104 ×1.0

IMMUN

124 ×1.3

64 ×0.7

EPIDE

47 ×0.6

HEPAT

21 ×0.3

PHYSI

Citations per year, relative to Hai-Xing Jiang Hai-Xing Jiang (= 1×) peers Palma Aurelia Iacovazzi

Countries citing papers authored by Hai-Xing Jiang

Since Specialization

Citations

This map shows the geographic impact of Hai-Xing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai-Xing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai-Xing Jiang more than expected).

Fields of papers citing papers by Hai-Xing Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai-Xing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai-Xing Jiang. The network helps show where Hai-Xing Jiang may publish in the future.

Co-authorship network of co-authors of Hai-Xing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hai-Xing Jiang. A scholar is included among the top collaborators of Hai-Xing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai-Xing Jiang. Hai-Xing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuang, Wenxi, et al.. (2025). Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway. Cancer Medicine. 14(13). e70956–e70956. 1 indexed citations

Yang, Zhe, et al.. (2024). EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer. BMC Cancer. 24(1). 268–268. 7 indexed citations

Wei, Xueyan, et al.. (2024). SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-κB pathway. Biochemical Pharmacology. 230(Pt 2). 116580–116580. 3 indexed citations

Lu, Donghong, et al.. (2020). The relationship between cardiac muscularis propria and clinical outcomes of peroral endoscopic myotomy in achalasia. Clinics and Research in Hepatology and Gastroenterology. 45(4). 101529–101529. 3 indexed citations

Qin, Shanyu, et al.. (2020). Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis. Life Sciences. 264. 118677–118677. 28 indexed citations

Wang, Fei, et al.. (2019). Crosstalk network among multiple inflammatory mediators in liver fibrosis. World Journal of Gastroenterology. 25(33). 4835–4849. 52 indexed citations

Guo, Xiaoyun, et al.. (2018). CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway. Biomedicine & Pharmacotherapy. 105. 282–289. 30 indexed citations

Lu, Donghong, et al.. (2018). IL-22 inactivates hepatic stellate cells via downregulation of the TGF-β1/Notch signaling pathway. Molecular Medicine Reports. 17(4). 5449–5453. 19 indexed citations

Cheng, Shi, et al.. (2017). IL-9 promotes proliferation and metastasis of hepatocellular cancer cells by activating JAK2/STAT3 pathway.. PubMed. 10(7). 7940–7946. 10 indexed citations

10.

Hu, Bang-li, et al.. (2017). Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis. BioMed Research International. 2017. 1–9. 34 indexed citations

11.

Zhang, Liming & Hai-Xing Jiang. (2015). 2144 High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. European Journal of Cancer. 51. S381–S381. 1 indexed citations

12.

Qin, Shanyu, et al.. (2014). Association of interleukin 22 polymorphisms with gastric cancer risk. Tumor Biology. 36(3). 2033–2039. 19 indexed citations

13.

Su, Yingjie, et al.. (2012). [The expression and clinical significance of SphK1 and nuclear factor-κB p65 in human colon carcinoma].. PubMed. 51(3). 220–4. 3 indexed citations

14.

Qin, Shanyu, et al.. (2012). Effect of Helicobacter pylori Eradication on Blood Ammonia Levels in Cirrhotic Patients: A Systematic Review. Hepatogastroenterology. 59(120). 2576–81. 5 indexed citations

15.

Liu, Shiquan, et al.. (2012). Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. International Journal of Colorectal Disease. 27(12). 1569–1578. 40 indexed citations

16.

Qin, Shanyu, et al.. (2012). Inhibition of hepatic stellate cell proliferation by bone marrow mesenchymal stem cells via regulation of the cell cycle in rat. Experimental and Therapeutic Medicine. 4(3). 375–380. 10 indexed citations

17.

Jiang, Hai-Xing, et al.. (2012). [Activation of hepatocyte growth factor-induced apoptosis in hepatic stellate cells].. PubMed. 20(9). 698–702. 3 indexed citations

18.

Jiang, Hai-Xing. (2010). Investigation of bone marrow mesenchymal stem cells on apoptosis of hepatic fibrosis rats of hepatic stellate cells and the expression of Caspase-3. 1 indexed citations

19.

Wang, Linlin, et al.. (2004). [Association of HLA-DQA1 loci with Helicobacter pylori infection in children of Guangxi Zhuang, Mulam nationalities, China and central Jing nationality, Vietnam].. PubMed. 42(8). 577–80. 1 indexed citations

20.

Shi, Huan‐Zhong, Jingmin Deng, Hui Xu, et al.. (1998). Effect of Inhaled Interleukin-4 on Airway Hyperreactivity in Asthmatics. American Journal of Respiratory and Critical Care Medicine. 157(6). 1818–1821. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact